Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN) [Neutrals]

BHVN Rating Summary

BHVN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BHVN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $97.78 (+36.9%) * Over Last 12-Mos
Rating Score: 7.9 / 10   Percentile Rank: 81%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/10/2020 Oppenheimer Esther Rajavelu Downgrade Perform
(Outperform)
51.00
(67.00)
51.25
(71.44)
39.4% Details
4/9/2019 Morgan Stanley
» Updated 12/24/2020
Matthew Harrison Downgrade Equalweight
(Overweight)
73.00
(N/A)
50.19
(71.44)
42.34% Details
Like BHVN Ratings? Also take a look at RPRX, TENX, FBIO, BIOD

BHVN Ratings News